Dong-Qing Hu

Author PubWeight™ 6.38^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	RN486, a selective Bruton's tyrosine kinase inhibitor, abrogates immune hypersensitivity responses and arthritis in rodents.	J Pharmacol Exp Ther	2012	1.09
2	Dynamic microRNA expression during the transition from right ventricular hypertrophy to failure.	Physiol Genomics	2012	1.05
3	Deletion of the β2-adrenergic receptor prevents the development of cardiomyopathy in mice.	J Mol Cell Cardiol	2013	0.93
4	Selective inhibition of spleen tyrosine kinase (SYK) with a novel orally bioavailable small molecule inhibitor, RO9021, impinges on various innate and adaptive immune responses: implications for SYK inhibitors in autoimmune disease therapy.	Arthritis Res Ther	2013	0.90
5	Physiologic and molecular characterization of a murine model of right ventricular volume overload.	Am J Physiol Heart Circ Physiol	2013	0.83
6	3-Amido pyrrolopyrazine JAK kinase inhibitors: development of a JAK3 vs JAK1 selective inhibitor and evaluation in cellular and in vivo models.	J Med Chem	2012	0.81
7	Selective pharmacological blockade of the TRPV1 receptor suppresses sensory reflexes of the rodent bladder.	J Urol	2009	0.80
8	miR-21 is associated with fibrosis and right ventricular failure.	JCI Insight	2017	0.75